The University of Colorado Center for Advanced Reproductive Medicine has been chosen by the National Institutes of Health (NIH) to participate in several critical research efforts. The National Institutes of Health is the primary organization in the United States that promotes and funds the most important research performed in this country. NIH is an arm of the federal government and all funding awarded by NIH represent the highest research accomplishment in the country. Very few researchers or organizations ever obtain research funding from the NIH to conduct clinical trials. NIH has continuously funded university of Colorado Advanced Reproductive Medicine since the mid 1990s. The most important clinical research networks in the country are funded through the NIH, and University of Colorado Reproductive Medicine has not one, but three funded Centers.
The Reproductive Medicine Network was established in the 1990s to solicit and fund research into the most important aspects of reproductive medicine. These research projects include both men and women and have resulted in critically important findings that have been published in the best journals in the world including the New England Journal of Medicine. In 2000, University of Colorado Advanced Reproductive Medicine was chosen as one of eight national sites, which also included the University of Pennsylvania, Pennsylvania State University, the University of Medicine and Dentistry of New Jersey, Wayne State University, Baylor College of Medicine, the University of Alabama, and the University of Texas Southwestern. The Reproductive Medicine Network published critical information from Advanced Reproductive Medicine about infertility treatment, the diagnosis and treatment of luteal phase abnormalities, and most recently a study that defined the relative effectiveness of clomiphene versus metformin in treatment of infertile women with polycystic ovarian syndrome. The initial period of participation in the Reproductive Medicine Network was from 2000 to 2007. In 2007 the NIH held another competition for inclusion in the RMN. Once again, University of Colorado Advanced Reproductive Medicine was chosen, this time as one of only seven universities to be honored. The other six medical schools are the University of Pennsylvania, Pennsylvania State University, Wayne State University, the University of Texas at San Antonio, the University of Michigan, and the University of Vermont.
Being named as a research unit of the NIH Reproductive Medicine Network reinforces the extraordinarily high quality of the clinical care and research being provided in this practice. Furthermore, participation in the RMN ensures that doctors, nurses, and other personnel at Advanced Reproductive Medicine are fully informed of progress in the field.
In 1998, University of Colorado Advanced Reproductive Medicine was chosen to be one of nine sites participating in the Contraceptive Clinical Trial Network. The purpose of this network is to develop and test new and effective approaches to contraception. This is important to all patients because a thorough understanding of reproduction biology helps physicians and University of Colorado Advanced Reproductive Medicine to expand information about all aspects including both contraception and promotion of fertility. After successfully participating in the Contraceptive Clinical Trials Network for five years, the NIH required a re-competition and University of Colorado Advanced Reproductive Medicine was again awarded participation in the Contraceptive Clinical Trial Network in 2005 for the period 2005 to 2011.